Researchers have found that the infection of cells with SARS-CoV-2 results in increased levels of a protein called CD47 on the cell surface.
CD47 is a so-called ‘do not eat me’ signal to the immune system’s defences that protect cells from being destroyed. Virus-induced CD47 on the surface of infected cells is likely to protect them from immune system recognition, enabling the production of larger amounts of virus, resulting in more severe disease.
Well-known risk factors for severe COVID-19 such as older age and diabetes are associated with higher CD47 levels. High CD47 levels also contribute to high blood pressure, which is a large risk factor for COVID-19 complications such as heart attack, stroke, and kidney disease.
Since therapeutics targeting CD47 are in development, this discovery may result in improved COVID-19 therapies.
Professor Martin Michaelis, University of Kent, said: ‘This is exciting. We may have identified a major factor associated with severe COVID-19. This is a huge step in combatting the disease and we can now look forward to further progress in the design of therapeutics.’
Professor Jindrich Cinatl, Goethe-University Frankfurt, said: ‘These additional insights into the disease processes underlying COVID-19 may help us to design better therapies, as well as appreciation for the importance of the breadth of research being conducted. Through this avenue, we have achieved a major breakthrough and exemplified that the fight against the disease continues.’
The study ‘A potential role of the CD47-SIRPalpha axis in COVID-19 pathogenesis’ is published by the scientific journal Current Issues in Molecular Biology (Katie-May McLaughlin, Dr Mark Wass, Professor Martin Michaelis – University of Kent; Dr Denisa Bojkova, Marco Bechtel, Joshua D. Kandler, Philipp Reus, Trang Le, Dr Julian U. G. Wagner, Professor Sandra Ciesek, Professor Jindrich Cinatl – Goethe University Frankfurt).
Source: Eurekalert
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsAzi is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
